EC3 Consulting · ECMO Litigation

ECMO Malpractice Cases: What Attorneys Need to Know

By André Fallot, MD, MPH  ·  March 2026  ·  10 min read

← All Articles

1. What ECMO Is and Why It Matters for Litigation

Extracorporeal membrane oxygenation — ECMO — is a life support system that takes over the function of the heart, lungs, or both when those organs fail to sustain life. Blood is drained from the patient's venous system, pumped through an artificial membrane oxygenator that removes carbon dioxide and adds oxygen, then returned to the patient. In venovenous (VV) ECMO, only the lungs are bypassed; in venoarterial (VA) ECMO, both heart and lung function are supported.

ECMO is used for some of the most critically ill patients in medicine: children in refractory respiratory failure, adults with cardiac arrest who don't respond to standard resuscitation, patients with massive pulmonary embolism, and patients awaiting cardiac transplantation. When it works, it is life-saving. When something goes wrong — wrong patient, wrong timing, wrong circuit management — the consequences can be fatal or permanently catastrophic.

For attorneys, ECMO cases are distinctive in several ways:

"ECMO cases are among the most technically demanding in pediatric malpractice. The expert who can't explain what an oxygenator does in terms a juror understands has already lost the case."

2. Who Gets ECMO: Patient Selection and Initiation Criteria

One of the most fertile areas for both plaintiff and defense litigation is the ECMO initiation decision itself. ECMO is not indicated for every patient in respiratory or cardiac failure — it is reserved for patients who meet specific criteria and who are unlikely to survive without it, while having sufficient potential for recovery to justify the risks.

Key criteria for ECMO candidacy (pediatric)

While criteria vary by institution and evolve over time, the general framework for pediatric ECMO candidacy includes:

Litigation arises at both ends of this spectrum. A patient who clearly met criteria but did not receive timely ECMO — or was transferred too late to an ECMO center — generates a delayed initiation claim. A patient who was placed on ECMO despite relative contraindications and suffered an ECMO complication generates an inappropriate candidacy claim.

Practical note: The OI and P/F ratio thresholds are guidelines, not absolute cutoffs. ECMO decisions are ultimately clinical judgments made in real time. Expert testimony must reflect that nuance — neither "the number was above the threshold therefore ECMO was required" nor "no threshold was crossed therefore ECMO was optional" is a complete or accurate characterization.

3. Common Theories of Liability in ECMO Cases

ECMO malpractice cases tend to cluster around a handful of recurring theories. Understanding which theory your case fits — and what clinical evidence you need to support it — is the starting point for expert selection.

Delayed Initiation

  • Patient met ECMO criteria but was not offered ECMO
  • Transfer to ECMO-capable center was unreasonably delayed
  • Documentation shows criteria met; no clinical rationale for delay
  • Requires expert on: criteria, transfer standards, retrieval ECMO

Inappropriate Candidacy

  • ECMO initiated in a patient who didn't meet criteria
  • Known contraindication was present and ignored
  • Inadequate pre-ECMO workup (neuro imaging, coag studies)
  • Requires expert on: candidacy evaluation, informed consent

Circuit Management Errors

  • Anticoagulation out of range (over- or under-targeted ACT/anti-Xa)
  • Failure to recognize oxygenator failure or clot formation
  • Inappropriate circuit change timing
  • Pump speed errors causing hemolysis or inadequate flow

Complication Management

  • Failure to recognize and treat limb ischemia (VA-ECMO)
  • Intracranial hemorrhage — unrecognized or inadequately managed
  • ECMO-related thrombosis with systemic embolism
  • Failure to wean despite recovery criteria met

Decannulation / Weaning

  • Premature decannulation before adequate recovery
  • Excessive continuation when recovery criteria clearly met
  • Vascular injury at decannulation
  • Failure to perform vascular repair after VA-ECMO removal

Informed Consent

  • Failure to disclose known ECMO risks (stroke, hemorrhage, limb loss)
  • Inadequate disclosure of alternatives
  • Consent obtained under inappropriate time pressure
  • Surrogate consent issues in pediatric patients

4. ELSO Guidelines and the Standard of Care

The Extracorporeal Life Support Organization (ELSO) is the primary professional body governing ECMO practice worldwide. ELSO publishes a comprehensive set of guidelines — updated regularly — covering patient selection, anticoagulation management, circuit components, complications, and specific patient populations including neonates, pediatric patients, and adults.

For litigation purposes, ELSO guidelines serve as the most direct articulation of what the standard of care requires in ECMO management. They are widely followed, published by the recognized specialty authority, and peer-reviewed. In most jurisdictions, departure from ELSO guidelines is a strong foundation for a standard-of-care opinion — and compliance with ELSO guidelines is the most effective defense.

Key ELSO documents relevant to litigation

The version of ELSO guidelines in effect at the time of the clinical event — not the current version — defines the applicable standard. Your expert must be able to testify to historical guideline versions, not just current practice.

When ELSO guidelines don't answer the question

ELSO guidelines set a floor, not a ceiling. For many specific management decisions — the exact ACT target for a particular patient on anticoagulation, the timing of a circuit change in the presence of partial clotting, the decision to use a distal perfusion catheter in a specific VA-ECMO configuration — the guidelines provide a framework rather than a precise answer. Expert testimony must fill that space with current clinical judgment, not just guideline citation.

Conversely, defense counsel will sometimes argue that ECMO care is so individualized and judgment-dependent that no clear standard can be established for a given decision. This argument has its limits: for discrete, documentable decisions — initiation, anticoagulation targets, complication recognition — the ELSO guidelines and published literature do establish clear expectations that an expert can articulately defend.

5. Expert Witness Requirements for ECMO Cases

The single most important qualification for an ECMO expert witness is personal, current, hands-on ECMO management experience. This requirement is more demanding than it sounds.

What "ECMO experience" actually means

Many physicians who work in ICU settings have some familiarity with ECMO. But there is a meaningful difference between:

For most ECMO malpractice cases, the third level of expertise produces meaningfully better testimony. The expert who can say "I personally made this type of decision last week" is categorically more credible than the expert who says "at my institution, the perfusionist usually handles that."

Institutional factors that matter

Not all ECMO programs are structured the same way. At some centers, ECMO management is shared between perfusionists, intensivists, and cardiac surgeons with overlapping responsibilities. At others — typically smaller PICU programs — the intensivist manages ECMO parameters directly without a dedicated perfusionist team.

An expert from the latter type of program brings a level of direct clinical responsibility that differs meaningfully from one who practices ECMO in a high-volume quaternary center with multiple overlapping specialists. Both can be credible experts, but the basis and scope of their testimony will differ — and you should understand which you are working with before retaining them.

EC3 Consulting's ECMO position: Dr. Fallot directs a 20-bed PICU that runs ECMO without a dedicated perfusionist team or cardiac surgery service. ECMO circuit management — including anticoagulation, flow parameters, oxygenator assessment, and decannulation decisions — rests with the intensivist. This direct, independent clinical responsibility produces expert testimony grounded in exactly the type of decision-making that most ECMO malpractice cases place at issue.

6. ECMO Complications and Their Legal Significance

ECMO carries serious inherent risks — complications occur even with optimal management. The legal question is almost always whether a specific complication resulted from a departure from the standard of care, or whether it was an unavoidable consequence of the therapy in a critically ill patient.

Neurological complications

Stroke — both hemorrhagic and ischemic — is the most feared ECMO complication and the most frequent source of wrongful death and serious injury litigation. Hemorrhagic stroke is directly related to ECMO anticoagulation; ischemic stroke reflects thromboembolism from the circuit or altered cerebral perfusion. The key litigation questions are: Was anticoagulation managed within guideline targets? Were neurological changes recognized promptly? Was appropriate neuroimaging obtained? Was ECMO continued or weaned appropriately after neurological injury?

Limb ischemia (VA-ECMO)

Venoarterial ECMO cannulation of the femoral artery places the distal limb at risk of ischemia. ELSO guidelines and standard practice call for placement of a distal perfusion catheter (DPC) in most cases to maintain perfusion below the arterial cannulation site. Failure to recognize limb ischemia — or failure to place a DPC in the first instance — is a recurring theory of liability that is well-supported by the literature.

Hemorrhagic complications

Bleeding at cannulation sites, pulmonary hemorrhage, GI bleeding, and surgical site bleeding are common ECMO complications related to systemic anticoagulation. The litigation question focuses on whether anticoagulation was appropriately titrated, whether bleeding was recognized early, and whether the decision to continue anticoagulation in the face of bleeding was within the standard of care.

Circuit thrombosis

Clot formation in the ECMO circuit — oxygenator, tubing, or pump head — is a serious complication requiring circuit change. Failure to recognize developing circuit thrombosis (assessed through visual inspection, ACT trends, D-dimer, and oxygenator performance metrics) is a recognizable standard-of-care failure that an experienced ECMO expert can clearly articulate.

7. How to Assess an ECMO Case Before Retaining an Expert

Before you commit resources to an ECMO case, a preliminary record review can identify whether a viable theory of liability exists. Here is a practical framework:

  1. Identify the ECMO type: VV (respiratory) or VA (cardiac/cardiac-respiratory). The applicable standards differ, and so does the expert you need.
  2. Locate the ECMO flow sheet: ECMO management is documented in real time on a dedicated flow sheet tracking pump speed, flows, anticoagulation levels, sweep gas settings, and FiO2. This is often the single most important document in an ECMO case.
  3. Review anticoagulation records: ACT, anti-Xa, and aPTT values trending over the ECMO course — particularly at the time of the adverse event — are essential for hemorrhagic or thrombotic complication cases.
  4. Determine the institutional ECMO team structure: Who at this institution manages ECMO parameters — the intensivist, the perfusionist, or a shared model? This affects expert selection and the scope of defendants.
  5. Identify the initiation decision and timing: When was ECMO initiated? What were the OI/P/F values at initiation? Was there documented consideration of ECMO earlier in the clinical course? If so, why was it deferred?
  6. Review the neurological record: Were neurological exams documented regularly during ECMO? Was head ultrasound or CT performed at appropriate intervals? What was found?
  7. Assess the decannulation record: What criteria were used for weaning? Were they consistent with ELSO guidance? Was vascular integrity confirmed after VA-ECMO removal?

With these records in hand, a preliminary consultation with an experienced ECMO expert will quickly identify whether a viable case exists — and which specific theory of liability has the most evidentiary support.

EC3 Consulting offers a no-charge preliminary case consultation for ECMO matters. We can typically provide an initial assessment of case viability within 2–3 weeks of record receipt. Call (918) 246-6364 or contact us through our inquiry form to start the conversation.

André Fallot, MD, MPH

André Fallot, MD, MPH — FAAP · FCCP · COL (Ret), U.S. Army

Triple board-certified in general pediatrics, pediatric pulmonology, and pediatric critical care. Medical Director, PICU — Saint Francis Children's Hospital, Tulsa, OK. Fellowship trained at UCSF (pediatric pulmonology) and Seattle Children's / University of Washington (pediatric critical care). Operates ECMO independently without cardiac surgery or dedicated perfusionist backup. Over 25 expert witness cases; 14+ depositions.

Back to all articles  |  Also see: What to Look for in a Pediatric Critical Care Expert Witness

Have an ECMO Case to Discuss?

Initial consultations are confidential and without obligation. Dr. Fallot responds to ECMO case inquiries personally within one business day.

Call (918) 246-6364 Send an Inquiry